exenatide

Related to exenatide: Pramlintide

ex·en·a·tide

(ĕk′sĕn′ə-tīd′, ĭg-zĕn′-)

An injectable drug that is a synthetic analog of a digestive hormone and stimulates insulin secretion when blood sugar levels are high, used to treat type 2 diabetes.

[exen(din-4), peptide found in the saliva of the Gila monster, of which exenatide is a synthetic version (ex(ocrine) + end(ocrine) + -in, due to the fact that it is an exocrine secretion with endocrine activity) + peptide.]

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

Translations

exenatide

n exenatida

References in periodicals archive ?

Middle East and Africa (MEA) and Latin America regions will show slower growth rate as compared to North America, as well as a comparatively low market revenue share Exenatide and Others Segments Have a Tie The exenatide and others segments by drug class show similar growth rate and hence can be said to congruently move along during the period of forecast.

Peptide Based Metabolic Disorders Therapeutics Market: Hospital Pharmacies Segment Shows Supremacy

M2 EQUITYBITES-April 5, 2019-Oramed announces US patent for oral Exenatide

Oramed announces US patent for oral Exenatide

Global Banking News-April 5, 2019-Oramed announces US patent for oral Exenatide

Oramed announces US patent for oral Exenatide

M2 PHARMA-April 5, 2019-Oramed announces US patent for oral Exenatide

Oramed announces US patent for oral Exenatide

ITCA 650 is an implantable device which delivers sustained and stable concentrations of the glucagon-like peptide 1 receptor agonist exenatide, when inserted subcutaneously.

Exenatide implant therapy in diabetes

Exenatide is a GLP-1 R agonist that is resistant to DPP-IV and has a longer half-life, which makes it attractive for clinical applications (10).

Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease

Exenatide is a synthetic derivative of exendin-4, a peptide found in the saliva of the Gila monster [4].

Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance

NEW YORK -- AstraZeneca announced that the Food and Drug Administration has approved Bydureon BCise (exenatide extended-release) injectable suspension, a new formulation of Bydureon in an improved once-weekly, single-dose autoinjector device for adults with type 2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines in addition to diet and exercise, to improve glycemic control.

Bydureon BCise Autoinjector Is Approved by FDA

Existing treatments merely ameliorate symptoms of Parkinson's, such as tremors and stiffness, but the study published in The Lancet suggests that the drug exenatide targets its underlying cause.

MINUTES ON... 36 DAILY MIRROR FRIDAY 27.10.2017 DMUULS FRIDA DR MIRIAM STOPPARD Helping to keep you fit and healthy miriam@mirror.co.uk @MiriamStoppard New hope for Parkinson's

PATIENTS WITH TYPE 2 diabetes who took once-daily exenatide did not appear to have an increase in their overall cardiovascular risk, compared with those who took placebo, a large randomized trial demonstrated.

No increased overall cardiovascular risk seen with exenatide use

Synthetic exendin-4 was approved as exenatide for twice-daily injection by the US Food and Drug Administration (FDA) in 2005, becoming the first GLP-1 receptor agonist (GLP-IRA).